8th Expanded Access Progammes World Congress 2025 Europe
Comprehensive Analysis on Executing Expanded Access Programmes
Wednesday 19th - Thursday 20th March 2025

Dr David Gillen
Chief Medical Officer

Katja Berg
Innovative Value and Access Strategy

ADAM JONES
Vice President International Medical

Sara Radenovic*
Director, Managed Access

SHEELA UPADHYAYA
Chair Elect, Rare Disease Special Interest Group

DAN LEWI
Head of Business Development and Patient Advocacy
Pulse infoframe Inc., Co- founder, CATS Foundation

DAN LEWI
Head of Business Development and Patient Advocacy

JENNIFER GRIGONIS
Sr. Director Business Development, EAP

Lindsay Randall
Founder, CEO, Mother

Dr. Alberto Calabrò
Patient Access Program and Supply Leader

Ana Tediosi
Head of Expanded Access Strategy

DR MICHELE AFIF
CEO

Pedro Franco
Sr Director, Head, Europe Global Regulatory & Scientific Policy

JULIE POWELL
Marketing & Communications Director

Carole Scrafton
Director & Co-Founder

JULIET HULSE
Head of Clinical Operations

DANIEL O’CONNOR
Director, Regulatory Policy and Early Access

Bob Stevens
Group CEO

DR POOJA TAKHAR
Joint Chief Executive Shortly

Senior Representative
Awaiting for Photo & Bio

Senior Representative
Awaiting for Photo & Bio